| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/11/2023 |
SC 13D/A
| Novo Holdings A/S reports a 12% stake in IO Biotech, Inc. |
| 08/11/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Bought 2,469,135 shares
@ $2.025, valued at
$5M
Bought 2,469,135 warrants
@ $2.47, valued at
$6.1M
|
|
| 08/03/2023 |
SC 13D/A
| Novo Holdings A/S reports a 4.4% stake in Cyteir Therapeutics, Inc. |
| 07/26/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Sold 11,000 shares
@ $2.7365, valued at
$30.1k
Sold 21,100 shares
@ $2.7488, valued at
$58k
Sold 6,500 shares
@ $2.7574, valued at
$17.9k
|
|
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Sold 8,437 shares
@ $1.7905, valued at
$15.1k
Sold 31,978 shares
@ $1.7727, valued at
$56.7k
|
|
| 06/28/2023 |
SC 13G/A
| Novo Holdings A/S reports a 4.8% stake in Disc Medicine, Inc. |
| 06/28/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 1,250,000 shares
@ $46.1, valued at
$57.6M
|
|
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2023 |
SC 13G/A
| Novo Holdings A/S reports a 4.9% stake in Galera Therapeutics, Inc. |
| 06/28/2023 |
SC 13D/A
| Novo Holdings A/S reports a 9.6% stake in Edgewise Therapeutics, Inc. |
| 06/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
SC 13G/A
| Novo Holdings A/S reports a 0% stake in VectivBio Holding AG |
| 05/15/2023 |
SC 13D/A
| Novo Holdings A/S reports a 10.2% stake in Reneo Pharmaceuticals, Inc. |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/24/2023 |
SC 13D/A
| Novo Holdings A/S reports a 11.7% stake in LAVA Therapeutics N.V. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/02/2023 |
SC 13G/A
| Novo Holdings A/S reports a 5.3% stake in VectivBio Holding AG |
| 02/02/2023 |
SC 13G/A
| Novo Holdings A/S reports a 9.8% stake in Evotec SE |
| 01/04/2023 |
SC 13D/A
| Novo Holdings A/S reports a 0% stake in Bolt Biotherapeutics, Inc. |
| 01/03/2023 |
3
| Novo Holdings A/S (10% Owner) has filed a Form 3 on Disc Medicine, Inc. |
| 01/03/2023 |
SC 13G
| Novo Holdings A/S reports a 13.8% stake in Disc Medicine, Inc. |
| 12/28/2022 |
SC 13D/A
| Novo Holdings A/S reports a 6.7% stake in Bolt Biotherapeutics, Inc. |
| 12/12/2022 |
SC 13G/A
| Novo Holdings A/S reports a 4% stake in Arcellx, Inc. |
| 11/28/2022 |
SC 13G/A
| Novo Holdings A/S reports a 5.7% stake in Arcellx, Inc. |
| 11/17/2022 |
SC 13G
| Novo Holdings A/S reports a 6.2% stake in Rallybio Corporation |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/03/2022 |
SC 13G/A
| Novo Holdings A/S reports a 4.5% stake in Minerva Surgical, Inc. |
| 10/24/2022 |
SC 13D/A
| Novo Holdings A/S reports a 4.6% stake in Milestone Pharmaceuticals Inc. |
|